I Avni, HJ Garzozi, IS Barequet, F Segev,
D Varssano… - Ophthalmology, 2010 - Elsevier
OBJECTIVE: To explore the safety and efficacy of CF101, an A3 adenosine receptor agonist,
in patients with moderate to severe dry eye syndrome. DESIGN: Phase 2, multicenter …